Navigation Links
Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
Date:2/25/2013

meHalozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the absorption and dispersion of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Safe Harbor StatementIn addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning the Company's expected net cash burn for 2013, the development and commercialization of products and the potential benefits and attributes of such products) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including unexpected expenditures and costs, unexpected results or delays in development and regulatory review, regulatory approval requirements, unexpected adverse event and competi
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
2. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
3. Halozyme to Host Third Quarter Financial Results Conference Call
4. Halozyme Reports Second Quarter 2012 Financial Results
5. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
6. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
7. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
8. Halozyme Reports First Quarter 2012 Financial Results
9. Halozyme to Host First Quarter 2012 Financial Results Conference Call
10. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
11. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22, 2015  ViewRay™, a privately held medical device ... exclusive distributor agreement with ITOCHU Corporation (Tokyo Stock Exchange ... for the treatment of cancer in Japan ... the world,s first and only MRI-guided radiation therapy system ...
(Date:1/22/2015)... Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty ... disease and overall health is pleased to provide you with ... outlook for 2015 from the CEO, Mr. Eugene Bortoluzzi ... like to take this opportunity to share with you the ...
(Date:1/22/2015)... Jan. 22, 2015 Increasing sophistication among enterprise buyers ... localization purchasing in 2015, says Moravia CMO, ... recent study by market research firm Common Sense Advisory, ... for their translation and localization needs. "From a language ...
Breaking Medicine Technology:ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... Laboratories, Inc. announced today that Senior National Account ... Pharmaceutical Representative of the Year Award at the ... NV on May 8, 2012.  The award was ... Purchasing at McKesson.  (Photo: ...
... TEL AVIV, Israel, May 22, 2012 Cephasonics, ... mixed-signal semiconductors, modules and subsystems to the imaging ... signed a distribution agreement with Tritech Ltd.  Tritech, ... be a key partner driving the success of ...
Cached Medicine Technology:Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation 2Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel 2
(Date:1/22/2015)... January 22, 2015 Liberty University has received ... program from the Council for Accreditation of Counseling ... of Liberty’s Center for Counseling & Family Studies , ... of the university’s new School of Behavioral Sciences. Prior to ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located in ... number one best large hotel for families in the United ... annual Travelers’ Choice Awards. , TripAdvisor represents the world’s ... to millions of unbiased and honest traveler reviews. The best ...
(Date:1/22/2015)... 2015 VogueQueen is a seasoned and trusted ... many designers are thrilled to have it lead the wedding ... new collection of prom dresses for the global market. , ... strategic vision and he focuses on continuing the goal of ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... a study by researchers at the University of Illinois at ... ads may be more effective than others. Adults and ... television. However, no research had been done on whether the ... on how the ads differ, says Sherry Emery, a senior ...
... DETROIT For the more than 36 million people ... on the condition, worsening the functional and emotional toll ... head and ears, according to a new study from ... a significant association between insomnia and the severity of ...
... years later, Sarah Clark grimaces sheepishly and insists she mishandled ... "I was woefully unprepared," says Clark, a researcher at ... High School in Ann Arbor. "I did not do a ... homework that night. I sent him to school the next ...
... , WEDNESDAY, April 18 (HealthDay News) -- Professional fighters may ... years in the ring -- where they can no longer ... study suggests. But, once they cross that threshold, years ... tolerate or absorb a certain amount of trauma and repair ...
... HealthDay Reporter , WEDNESDAY, April 18 (HealthDay News) -- ... more -- even gardening or puttering around the house ... more sedentary seniors. The study doesn,t confirm ... age-related degenerative brain disease. It,s possible that another factor ...
... and University of British Columbia have identified new breast ... is diagnosed and form the basis of next-generation treatments. ... new categories based on the genetic fingerprint of a ... into breast cancer biology, allowing doctors to predict whether ...
Cached Medicine News:Health News:Anti-tobacco TV ads help adults stop smoking, study finds 2Health News:Study: Insomnia takes toll on tinnitus patients 2Health News:Football helmet sensors help researchers demystify concussion in young athletes 2Health News:When Does Boxing-Related Head Trauma Become Too Much? 2Health News:When Does Boxing-Related Head Trauma Become Too Much? 3Health News:Everyday Activities Might Lower Alzheimer's Risk 2Health News:Everyday Activities Might Lower Alzheimer's Risk 3Health News:Scientists rewrite rulebook on breast cancer in landmark global study 2Health News:Scientists rewrite rulebook on breast cancer in landmark global study 3
... the features of our other HD Walkers, plus ... at an incredibly low price. Two adjustable ankle ... can be locked at 90 degrees, or set ... of dorsi or plantar flexion. Available in five ...
... a non-skid rocker outsole with a cushioned ... leg length discrepancies. Five hook & loop ... easy. Steel uprights are wider between the ... bandaging. This extra width insures easy application ...
Fracture walker designed to provide maximum comfort, protection and stability...
CAM Walker Fix the ankle or prescribe a range-of-motion. Features adjustable, double-action joints, fixed or up to 45 ROM. Lock-in dorsiflexion or plantar flexion....
Medicine Products: